NDC 73377-186 - Pentoxifylline
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-186
- Package NDCs from labels
- 73377-186-01, 73377-186-02
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pentoxifylline - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-03-10 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-186-01 | Pentoxifylline | 250 g in 1 JAR | POWDER | 250 | 3 | |
| 73377-186-02 | Pentoxifylline | 100 g in 1 JAR | POWDER | 100 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pentoxifylline | PENTOXIFYLLINE | Rising Pharma Holdings, Inc. | cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37 | 2026-05-15 | Adverse reactions | SD6QCT3TSU |
| Pentoxifylline | PENTOXIFYLLINE | ANI Pharmaceuticals, Inc. | 9ca79c97-e4e5-4297-85eb-7a9b3d8083b5 | 2025-11-07 | Adverse reactions | SD6QCT3TSU |
| PENTOXIFYLLINE | PENTOXIFYLLINE | Major Pharmaceuticals | 59c9a583-1f93-480f-879c-457a574374da | 2025-09-22 | Adverse reactions | SD6QCT3TSU |
| PENTOXIFYLLINE | PENTOXIFYLLINE | Bryant Ranch Prepack | 84816505-9253-41cf-8894-2b2d0e4aff67 | 2025-09-04 | Adverse reactions | SD6QCT3TSU |
| Pentoxifylline | PENTOXIFYLLINE | Bryant Ranch Prepack | c3ad4fb4-8995-46ab-86e9-7ec67ef607f9 | 2025-04-07 | Adverse reactions | SD6QCT3TSU |
| Pentoxifylline | PENTOXIFYLLINE | NCS HealthCare of KY, LLC dba Vangard Labs | bd2f2672-62cd-4e77-8b0b-782f5d06198b | 2024-10-22 | Adverse reactions | SD6QCT3TSU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.